Larvol Delta - AVM-Biotechnology-Awarded-2-Million-National-Cancer-Institute-SBIR-Phase-II-Grant-from-the-National-Institutes-of-Health-to-Advance-AVM0703-in-Cancer

dexamethasone sodium phosphate (AVM0703) - AVM Biotechnology

https://www.businesswire.com/news/home/20220614005414/en/AVM-Biotechnology-Awarded-2-Million-National-Cancer-Institute-SBIR-Phase-II-Grant-from-the-National-Institutes-of-Health-to-Advance-AVM0703-in-Cancer/

Jun 14, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next